Climb Bio, Inc.
6 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Phase 1b/2a Study of Budoprutug in Systemic Lupus Erythematosus (SLE) (NCT07564596) | Climb Bio, Inc. | 2026-06-30 |
| A Phase 1 Study of CLYM116 in Normal Healthy Volunteers (NCT07248865) | Climb Bio, Inc. | 2025-12-02 |
| A Phase 2 Study of Budoprutug in Subjects With Primary Membranous Nephropathy (NCT07096843) | Climb Bio, Inc. | 2025-08-25 |
| A Phase 1 Study of Budoprutug (TNT119) Subcutaneous and Intravenous Injections in Normal Healthy Volunteers (NCT07090655) | Climb Bio, Inc. | 2025-08-11 |
| A Phase 1b Study of Budoprutug in Systemic Lupus Erythematosus (SLE) (NCT07011043) | Climb Bio, Inc. | 2025-07-10 |
| A Phase 1b/2a Study of Budoprutug in Subjects With Immune Thrombocytopenia (ITP) (NCT07043946) | Climb Bio, Inc. | 2025-06-30 |
Track Climb Bio, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.